Publication | Closed Access

Efficacy and Safety Profile of Fluticasone Furoate Administered Once Daily in the Morning or Evening: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial in Adult and Adolescent Patients With Persistent Bronchial Asthma

AsthmaPersistent Bronchial AsthmaClinical AllergyAllergenPlacebo-controlled TrialPulmonary MedicineAllergic RhinitisMedicineSafety Profile